Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
Robin Minati, Claude Perreault, Pierre Thibault
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 483
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 93
The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
Mika L. Persson, Alicia M. Douglas, Frank Alvaro, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 9, pp. 1408-1422
Open Access | Times Cited: 49
Translation dysregulation in cancer as a source for targetable antigens
Chen Weller, Osnat Bartok, Christopher S. McGinnis, et al.
Cancer Cell (2025)
Open Access | Times Cited: 1
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Gabriele Antonarelli, Chiara Corti, Paolo Tarantino, et al.
Annals of Oncology (2021) Vol. 32, Iss. 12, pp. 1537-1551
Open Access | Times Cited: 54
Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
Charlotte Stutzmann, Jiaxi Peng, Zhaoguan Wu, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 6, pp. 100511-100511
Open Access | Times Cited: 18
Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability
Jenna Cleyle, Marie‐Pierre Hardy, Robin Minati, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 5, pp. 100228-100228
Open Access | Times Cited: 27
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
Yuqing Ren, Yi Yue, Xinyang Li, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113147-113147
Closed Access | Times Cited: 5
Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective
Vaishak Kaviyarasan, Alakesh Das, Dikshita Deka, et al.
International Journal of Colorectal Disease (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy
Jack Wadden, Karthik Ravi, Vishal John, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
Kim B. Nguyen, Malte Roerden, Christopher Copeland, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 10
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Progress and potential of nanobubbles for ultrasound-mediated drug delivery
L. Chen, Pinunta Nittayacharn, Agata A. Exner
Expert Opinion on Drug Delivery (2025)
Closed Access
Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
Mingfeng Jiang, Jun Li, Jianhua Wei, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus
Stefan Barisic, Elizabeth M. Brahmbhatt, Elena Cherkasova, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 9, pp. e009147-e009147
Open Access | Times Cited: 3
Tumour mutational burden: an overview for pathologists
Kenneth Doig, Andrew Fellowes, Prudence A. E. Scott, et al.
Pathology (2022) Vol. 54, Iss. 3, pp. 249-253
Open Access | Times Cited: 14
Genomics-Driven Precision Medicine in Pediatric Solid Tumors
Praewa Suthapot, Wararat Chiangjong, Parunya Chaiyawat, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1418-1418
Open Access | Times Cited: 8
MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets
Kevin A. Kovalchik, Qing Ma, Laura Wessling, et al.
Molecular & Cellular Proteomics (2021) Vol. 21, Iss. 1, pp. 100178-100178
Open Access | Times Cited: 17
Tumor Antigens beyond the Human Exome
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 2
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human
Cheryl Lai-Lai Chiang, Raphaël Rovelli, Apostolos Sarivalasis, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4553-4553
Open Access | Times Cited: 10
Pathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells
Chenyang Zhang, Ben J. E. Raveney, Fumio Takahashi, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 868-868
Open Access | Times Cited: 4
Multi-strategies embedded framework for neoantigen vaccine maturation
Guanqiao Zhang, Yaqi Fu, Chun Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
William Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes
Sang‐Hyun Kim, Ha-Eun Park, Seong-Un Jeong, et al.
Immune Network (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top